Neko Health

News

Spotify founder Daniel Ek's new business Neko Health has raised $260m to bring its body scanning clinics to new international markets.

News

Hengrui's oral TPO agonist, hetrombopag, is the first in the class to be approved for thrombocytopenia caused by chemotherapy for solid tumours.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.